Research + Innovation
Research and innovation is a vital component of the Global Polio Eradication Initiative, providing the necessary evidence and tools to guide the final steps to a lasting polio-free world and beyond. The Global Polio Eradication Initiative coordinates and supports an extensive programme of research and product innovation and development from a wide range of core scientific disciplines. The research programme has two broad objectives:
to identify, develop and evaluate new tools and tailored approaches to assess and sensitise to ensure the impact of eradication efforts is maximised
to inform long-term policy for the post-eradication era.
Current research areas include :
- Optimizing oral polio vaccine efficacy
- Developing affordable inactivated polio vaccine
- Managing risks associated with vaccine-derived polioviruses and vaccine-associated paralytic polio (including OPV cessation)
- Polio diagnostics
- Surveillance research
CALL FOR EXPRESSIONS OF INTEREST – Commercialization and technology transfer of Virus-Like-Particle Polio Vaccine
The World Health Organization is seeking Expressions of Interest from public- and private-sector vaccine manufacturers and other institutions on development and manufacture of affordable poliovirus virus-like-particle vaccine. Read the expression of Interest.